Calcium and body composition
What a review of calcium supplements showed for weight, waist and fat mass.
Key points
- In people with overweight or obesity, a review found no clear change in total body weight from calcium supplements versus placebo or a lower dose. No clear advantage was found for weight. [1] See the evidence 1
- In the same review, mean reductions in body mass index were small, about 0.18 kg/m², and in waist circumference about 0.51 cm relative to comparison. These are separate body composition measures. [1] See the evidence 1 2
- The estimate of fat-mass change allowed both a small decrease and a small increase versus control. The direction of effect remained uncertain for this outcome. [1] See the evidence 1
Practical guide
Check the conclusions and whether they apply to your situation.
The review assessed weight, body mass index, waist and fat mass separately.
Key points
Why these conclusions
Weight, waist and fat mass
A review of trials in people with overweight or obesity compared calcium supplements with placebo or a lower dose. No clear change in total body weight was found; certainty low, 2 out of 4. [1]
Mean differences for body mass index and waist circumference were about −0.18 kg/m² and −0.51 cm respectively; certainty 3 out of 4. Studies used 162–1,500 mg elemental calcium daily, most lasting less than six months. [1]
For fat mass, the estimate range included small changes in either direction; certainty very low, 1 out of 4. [1]
Calcium supplements showed no clear change in total body weight in people with overweight or obesity compared with placebo or a lower calcium dose.
| Parameter | Data |
|---|---|
| Result | Calcium supplements showed no clear change in total body weight in people with overweight or obesity compared with placebo or a lower calcium dose. |
| Participants | 1,317 participants with overweight or obesity, 17 RCTs |
| Form | oral calcium supplements, various salts |
| Dose | 162–1,500 mg elemental calcium/day |
| Dose basis | 162–1,500 mg elemental calcium/day |
| Comparator | placebo or lower calcium dose |
| Duration | most studies less than 6 months |
| Confidence | 2/4: Precision: Small sample or confidence interval permits different effects.; Consistency: Differences in interventions and populations are considered within the conclusion; data are insufficient for a separate quantitative downgrade.; Applicability to the specified group: Limited to the named group, composition, outcome and dose; do not extrapolate to other regimens.; Possible publication bias: Cannot be excluded; reliable outcome-specific assessment not established.; Study methods: Primary trials have limitations or incomplete assessment; a full RoB 2 for this result has not been independently completed. |
| Evidence base | 17 trials in the review |
| Sources | [1] |
The mean reduction in body mass index with calcium compared with placebo or a lower calcium dose was small, about 0.18 kg/m².
| Parameter | Data |
|---|---|
| Result | The mean reduction in body mass index with calcium compared with placebo or a lower calcium dose was small, about 0.18 kg/m². |
| Participants | People with overweight or obesity, 731 in 9 RCTs |
| Form | Calcium salts alone |
| Dose | 162–1,500 mg elemental calcium/day in the review |
| Dose basis | 162–1,500 mg elemental calcium/day in the review |
| Comparator | Placebo or lower calcium dose |
| Duration | 8 weeks–24 months, most studies shorter than six months |
| Confidence | 3/4: Precision: No separate downgrade is required for the stated wording.; Consistency: No significant between-study inconsistency for the conclusion was established or the estimate is from one study.; Applicability to the specified group: The conclusion is limited to the directly studied outcome and population.; Possible publication bias: No grounds for a separate downgrade.; Study methods: Quality limitations of primary RCTs. |
| Evidence base | 9 trials in the review |
| Sources | [1] |
The mean reduction in waist circumference with calcium compared with placebo or a lower calcium dose was small, about 0.51 cm.
| Parameter | Data |
|---|---|
| Result | The mean reduction in waist circumference with calcium compared with placebo or a lower calcium dose was small, about 0.51 cm. |
| Participants | People with overweight or obesity, 273 in 6 RCTs |
| Form | Calcium salts alone |
| Dose | 162–1,500 mg elemental calcium/day in the review |
| Dose basis | 162–1,500 mg elemental calcium/day in the review |
| Comparator | Placebo or lower calcium dose |
| Duration | 8 weeks–24 months, most studies shorter than six months |
| Confidence | 3/4: Precision: No separate downgrade is required for the stated wording.; Consistency: No significant between-study inconsistency for the conclusion was established or the estimate is from one study.; Applicability to the specified group: The conclusion is limited to the directly studied outcome and population.; Possible publication bias: No grounds for a separate downgrade.; Study methods: Quality limitations of primary RCTs. |
| Evidence base | 6 trials in the review |
| Sources | [1] |
The estimate of fat-mass change permitted both a small decrease and a small increase with calcium compared with placebo or a lower calcium dose.
| Parameter | Data |
|---|---|
| Result | The estimate of fat-mass change permitted both a small decrease and a small increase with calcium compared with placebo or a lower calcium dose. |
| Participants | People with overweight or obesity, 812 in 12 RCTs |
| Form | Calcium salts alone |
| Dose | 162–1,500 mg elemental calcium/day in the review |
| Dose basis | 162–1,500 mg elemental calcium/day in the review |
| Comparator | Placebo or lower calcium dose |
| Duration | 8 weeks–24 months, most studies shorter than six months |
| Confidence | 1/4: Precision: The CI crosses zero.; Consistency: I²=97%.; Applicability to the specified group: The conclusion is limited to the directly studied outcome and population.; Possible publication bias: No grounds for a separate downgrade.; Study methods: Quality limitations of primary RCTs. |
| Evidence base | 12 trials in the review |
| Sources | [1] |
More details
Who the results apply to
The results apply to participants with overweight or obesity and comparison with placebo or a lower calcium dose. [1]
Sources
- Calcium supplementation for people with overweight or obesity. https://pmc.ncbi.nlm.nih.gov/articles/PMC11079972/
Methodology: Subpages evidence-led supplement pipeline v1